Full text is available at the source.
Abstract
Meta-analyses indicate a protective effect for GLP-1 receptor agonists on stroke risk in individuals with type 2 diabetes.
- SGLT2 inhibitors and DPP-4 inhibitors show neutral findings regarding stroke risk.
- Observational studies suggest potential broader stroke risk reductions associated with these medications.
- The study utilized nationwide longitudinal data to estimate associations with stroke risk.
- Results were contextualized within existing meta-analyses of randomized controlled trials and observational studies.
Simplified